Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × OTHER × Has announcements × Clear all

Phase

Phase 3 4 Phase 2 2 Phase 1/2 2

Status

Sponsor Class

INDUSTRY 96 NIH 3 OTHER 2 NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Neoplasms 1 Graft vs Host Disease 1

Interventions

Eflornithine 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01743131 2025-12-11

Abatacept as GVHD Prophylaxis Phase 2

Boston Children's Hospital

Phase 2 Completed

186 enrolled 14 charts 1 FDA

Graft vs Host Disease, Neoplasms

NCT02395666 2024-08-06

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Milton S. Hershey Medical Center

Phase 2 Completed

140 enrolled 14 charts 1 FDA

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡